Xu B, Ma F, Wang T, Wang S, et al. A phase IIb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer who received at least two prior treatments. Int J Cancer 2023 Jan 9. doi: 10.1002/ijc.34424.
PMID: 36621000